Cargando…

Machine Learning-Based Virtual Screening and Molecular Simulation Approaches Identified Novel Potential Inhibitors for Cancer Therapy

Cyclin-dependent kinase 2 (CDK2) is a promising target for cancer treatment, developing new effective CDK2 inhibitors is of great significance in anticancer therapy. The involvement of CDK2 in tumorigenesis has been debated, but recent evidence suggests that specifically inhibiting CDK2 could be ben...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahab, Muhammad, Zheng, Guojun, Khan, Abbas, Wei, Dongqing, Novikov, Alexander S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452548/ https://www.ncbi.nlm.nih.gov/pubmed/37626747 http://dx.doi.org/10.3390/biomedicines11082251

Ejemplares similares

The use of machine learning modeling, virtual screening, molecular docking, and molecular dynamics simulations to identify potential VEGFR2 kinase inhibitors
por: Salimi, Abbas, et al.
Publicado: (2022)

Structure based virtual screening and molecular simulation study of FDA-approved drugs to inhibit human HDAC6 and VISTA as dual cancer immunotherapy
por: Shahab, Muhammad, et al.
Publicado: (2023)

Virtual screening approach to identifying influenza virus neuraminidase inhibitors using molecular docking combined with machine-learning-based scoring function
por: Zhang, Li, et al.
Publicado: (2017)

Integrated virtual screening, molecular modeling and machine learning approaches revealed potential natural inhibitors for epilepsy
por: Alshehri, Faez Falah
Publicado: (2023)

Structure-Based Virtual Screening of Tumor Necrosis Factor-α Inhibitors by Cheminformatics Approaches and Bio-Molecular Simulation
por: Halim, Sobia Ahsan, et al.
Publicado: (2021)

Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation
por: Samad, Abdus, et al.
Publicado: (2023)

Identifying Novel Inhibitors for Hepatic Organic Anion Transporting Polypeptides by Machine Learning-Based Virtual Screening
por: Tuerkova, Alzbeta, et al.
Publicado: (2022)

Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors
por: Di Stefano, Miriana, et al.
Publicado: (2022)

Machine Learning Models Combined with Virtual Screening and Molecular Docking to Predict Human Topoisomerase I Inhibitors
por: Li, Bingke, et al.
Publicado: (2019)

Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations
por: Almeleebia, Tahani M., et al.
Publicado: (2022)

High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1
por: Rehman, Md Tabish, et al.
Publicado: (2019)

High Throughput Virtual Screening and Molecular Dynamics Simulation for Identifying a Putative Inhibitor of Bacterial CTX-M-15
por: Shakil, Shazi, et al.
Publicado: (2021)

Identification of Potential Cytochrome P450 3A5 Inhibitors: An Extensive Virtual Screening through Molecular Docking, Negative Image-Based Screening, Machine Learning and Molecular Dynamics Simulation Studies
por: Islam, Md Ataul, et al.
Publicado: (2022)

Discovery of Cobimetinib as a novel A-FABP inhibitor using machine learning and molecular docking-based virtual screening
por: Yang, Shilun, et al.
Publicado: (2022)

Discovery of Novel Tankyrase Inhibitors through Molecular Docking-Based Virtual Screening and Molecular Dynamics Simulation Studies
por: Berishvili, Vladimir P., et al.
Publicado: (2020)

Machine-Learning-Enabled Virtual Screening for Inhibitors of Lysine-Specific Histone Demethylase 1
por: Zhou, Jiajun, et al.
Publicado: (2021)

Novel inhibitors to ADP ribose phosphatase of SARS-CoV-2 identified by structure-based high throughput virtual screening and molecular dynamics simulations
por: Patel, Dhrumi C., et al.
Publicado: (2022)

Virtual Screening and Molecular Dynamics Simulation Study of Influenza Polymerase PB2 Inhibitors
por: Zong, Keli, et al.
Publicado: (2021)

In Silico Prediction of Novel Inhibitors of SARS-CoV-2 Main Protease through Structure-Based Virtual Screening and Molecular Dynamic Simulation
por: Halim, Sobia Ahsan, et al.
Publicado: (2021)

Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
por: Zhang, Yi, et al.
Publicado: (2020)

Using Machine Learning and Molecular Docking to Leverage Urease Inhibition Data for Virtual Screening
por: Aniceto, Natália, et al.
Publicado: (2023)

Pharmaceutical Machine Learning: Virtual High-Throughput Screens Identifying Promising and Economical Small Molecule Inhibitors of Complement Factor C1s
por: Chen, Jonathan J., et al.
Publicado: (2018)

Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations
por: Shafie, Alaa, et al.
Publicado: (2021)

Identifying promising GSK3β inhibitors for cancer management: a computational pipeline combining virtual screening and molecular dynamics simulations
por: Hua, Libo, et al.
Publicado: (2023)

Multiple machine learning methods aided virtual screening of Na(V)1.5 inhibitors
por: Kong, Weikaixin, et al.
Publicado: (2022)

Sulfonanilide Derivatives in Identifying Novel Aromatase Inhibitors by Applying Docking, Virtual Screening, and MD Simulations Studies
por: Rampogu, Shailima, et al.
Publicado: (2017)

Screening, molecular simulation & in silico kinetics of virtually designed covid-19 main protease inhibitors
por: Aleissa, Mohammed S., et al.
Publicado: (2022)

Exploring the ability of machine learning-based virtual screening models to identify the functional groups responsible for binding
por: Hadfield, Thomas E., et al.
Publicado: (2023)

Based on the Virtual Screening of Multiple Pharmacophores, Docking and Molecular Dynamics Simulation Approaches toward the Discovery of Novel HPPD Inhibitors
por: Fu, Ying, et al.
Publicado: (2020)

Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches
por: Rehman, Hafiz Muzzammel, et al.
Publicado: (2023)

High-throughput virtual screening with e-pharmacophore and molecular simulations study in the designing of pancreatic lipase inhibitors
por: Veeramachaneni, Ganesh Kumar, et al.
Publicado: (2015)

Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies
por: Mohammad, Taj, et al.
Publicado: (2020)

Virtual screening of RAGE inhibitors using molecular docking
por: Devi Alaparthi, Malini, et al.
Publicado: (2016)

Virtual screening and molecular dynamics simulation analysis of Forsythoside A as a plant-derived inhibitor of SARS-CoV-2 3CLpro
por: Bibi, Shabana, et al.
Publicado: (2022)

Identification of novel bacterial urease inhibitors through molecular shape and structure based virtual screening approaches
por: Imran, Muhammad, et al.
Publicado: (2020)

Novel inhibitor discovery against aromatase through virtual screening and molecular dynamic simulation: a computational approach in drug design
por: Mirzaie, Sako, et al.
Publicado: (2013)

Design & discovery of small molecule COVID-19 inhibitor via dual approach based virtual screening and molecular simulation studies
por: Aljarba, Nada H., et al.
Publicado: (2022)

Identification of African Swine Fever Virus Inhibitors through High Performance Virtual Screening Using Machine Learning
por: Choi, Jiwon, et al.
Publicado: (2021)

Virtual Screening Based on Machine Learning Explores Mangrove Natural Products as KRAS(G12C) Inhibitors
por: Luo, Lianxiang, et al.
Publicado: (2022)

Pharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors
por: Gaurav, Anand, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bklhrhbjvbbeoan21v0182tl23